GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (TSE:4527) » Definitions » Shiller PE Ratio

Rohto Pharmaceutical Co (TSE:4527) Shiller PE Ratio : 42.83 (As of Apr. 27, 2024)


View and export this data going back to 1962. Start your Free Trial

What is Rohto Pharmaceutical Co Shiller PE Ratio?

As of today (2024-04-27), Rohto Pharmaceutical Co's current share price is 円3036.00. Rohto Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 was 円70.88. Rohto Pharmaceutical Co's Shiller PE Ratio for today is 42.83.

The historical rank and industry rank for Rohto Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

TSE:4527' s Shiller PE Ratio Range Over the Past 10 Years
Min: 29.56   Med: 38.72   Max: 62.06
Current: 41.18

During the past years, Rohto Pharmaceutical Co's highest Shiller PE Ratio was 62.06. The lowest was 29.56. And the median was 38.72.

TSE:4527's Shiller PE Ratio is ranked worse than
82.24% of 1070 companies
in the Consumer Packaged Goods industry
Industry Median: 18.64 vs TSE:4527: 41.18

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Rohto Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was 円41.800. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円70.88 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Rohto Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Rohto Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rohto Pharmaceutical Co Shiller PE Ratio Chart

Rohto Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.37 34.77 31.99 35.31 44.77

Rohto Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.61 44.77 49.54 59.56 40.11

Competitive Comparison of Rohto Pharmaceutical Co's Shiller PE Ratio

For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rohto Pharmaceutical Co's Shiller PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Rohto Pharmaceutical Co's Shiller PE Ratio falls into.



Rohto Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Rohto Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=3036.00/70.88
=42.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rohto Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Rohto Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=41.8/106.8000*106.8000
=41.800

Current CPI (Dec. 2023) = 106.8000.

Rohto Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 3.495 95.700 3.900
201406 2.850 98.000 3.106
201409 12.910 98.500 13.998
201412 9.995 97.900 10.904
201503 12.205 97.900 13.315
201506 5.820 98.400 6.317
201509 15.530 98.500 16.839
201512 12.850 98.100 13.990
201603 5.650 97.900 6.164
201606 6.010 98.100 6.543
201609 12.330 98.000 13.437
201612 18.470 98.400 20.047
201703 6.975 98.100 7.594
201706 9.945 98.500 10.783
201709 14.740 98.800 15.934
201712 19.470 99.400 20.919
201803 -3.565 99.200 -3.838
201806 15.035 99.200 16.187
201809 16.945 99.900 18.115
201812 15.535 99.700 16.641
201903 -4.700 99.700 -5.035
201906 9.690 99.800 10.370
201909 22.240 100.100 23.729
201912 22.980 100.500 24.421
202003 12.445 100.300 13.252
202006 7.635 99.900 8.162
202009 17.705 99.900 18.928
202012 21.460 99.300 23.081
202103 26.380 99.900 28.202
202106 20.760 99.500 22.283
202109 27.415 100.100 29.250
202112 26.605 100.100 28.386
202203 17.560 101.100 18.550
202206 30.560 101.800 32.061
202209 27.100 103.100 28.073
202212 36.910 104.100 37.867
202303 20.720 104.400 21.196
202306 39.730 105.200 40.334
202309 32.800 106.200 32.985
202312 41.800 106.800 41.800

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Rohto Pharmaceutical Co  (TSE:4527) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Rohto Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Rohto Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rohto Pharmaceutical Co (TSE:4527) Business Description

Traded in Other Exchanges
Address
1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co (TSE:4527) Headlines

No Headlines